Modified Immunotherapy Approach Shows Promise for Leukemia

Researchers have developed an immunotherapy approach that uses immune cells whose natural cancer killing abilities have been enhanced in the lab. In a small clinical trial, the treatment led to remissions in about half of patients with acute myeloid leukemia.

Cancer Currents: An NCI Cancer Research Blog